Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 45

Sort by

Sort Order Select

Journal Articles

Allogeneic Stem Cell Transplantation for Relapsed and/or Refractory Hodgkin Lymphoma: A Multicenter Real World Experience

Derya Koyun, Uğur Şahin, Güldane Cengiz Seval, Deniz Gören Şahin, Ayla Gökmen, Sinem Civriz Bozdağ, Selami Kocak Toprak, Pervin Topçuoğlu, Meltem Kurt Yüksel, Önder Arslan, Taner Demirer, Günhan Gürman, Osman İlhan, Meral Beksac, Muhit Özcan, Mutlu Arat

Blood (2023) 142 (Supplement 1): 3617.

https://doi.org/10.1182/blood-2023-182741

Published: 2023

Journal Articles

A Single Center Real-World Data Comparing Salvage Autologous Hematopoietic Stem-Cell Transplantation, Selinexor Combo and Elranatamab Alone Among Triple Class Refractory Myeloma Patients: Better Efficacy with Elranatamab

Guldane Cengiz Seval, Gul Yavuz, Gulcin Miyase Sonmez, Goren Arik, Fatma Selin Yildirim, Selami Kocak Toprak, Pervin Topçuoğlu, Meral Beksac

Blood (2023) 142 (Supplement 1): 6668.

https://doi.org/10.1182/blood-2023-173644

Published: 2023

Journal Articles

Single Center Real World Data That Compares Autologous Stem Cell Transplant in the Era of Anti-CD38 Monoclonal Antibody Based Treatments for AL Amyloidosis

Hulya Yilmaz, Guldane Cengiz, Bulent Karakaya, Gul Yavuz, Merve Aydogan, Sinem Civriz Bozdag, Selami Kocak Toprak, Meltem Kurt Yuksel, Pervin Topçuoğlu, Onder Arslan, Muhit Ozcan, Osman Ilhan, Meral Beksac

Blood (2022) 140 (Supplement 1): 4369–4370.

https://doi.org/10.1182/blood-2022-170132

Published: 2022

Journal Articles

The Impact of CD34+ Cell and Immunefector Cell Dose on Transplant Outcomes

Derya Koyun, Guldane Cengiz, Sinem Civriz Bozdag, Selami Kocak Toprak, Pervin Topçuoğlu, Muhit Özcan, Onder Arslan, Taner Demirer, Osman İlhan, Gunhan Gurman, Meral Beksac, Meltem Kurt Yuksel

Blood (2022) 140 (Supplement 1): 12673–12674.

https://doi.org/10.1182/blood-2022-155998

Published: 2022

Journal Articles

The Outcome of Autologous Hematopoietic Cell Transplantation in Elderly Patients with Aggressive Non-Hodgkin Lymphoma

Osman Ilhan, Guldane Cengiz Seval, Sinem Civriz Bozdag, Selami Kocak Toprak, Meltem Kurt Yuksel, Pervin Topcuoglu, Onder Arslan, Muhit Özcan, Taner Demirer, Gunhan Gurman, Meral Beksac

Blood (2021) 138 (Supplement 1): 4906.

https://doi.org/10.1182/blood-2021-153905

Published: 2021

Journal Articles

Comparison of Salvage Autologous Hematopoietic Cell Transplantation with Outcomes Following Selinexor Combinations Among Double/Triple Refractory Myeloma Patients

Guldane Cengiz, Bulent Karakaya, Hulya Yilmaz, Derya Koyun, Ekin Kircali, Sevgi Basboga, Selami Kocak Toprak, Sinem Civriz Bozdag, Meltem Kurt Yuksel, Pervin Topcuoglu, Gunhan Gurman, Trinayan Kashyap, James Niblock, Meral Beksac

Blood (2021) 138 (Supplement 1): 4904.

https://doi.org/10.1182/blood-2021-148835

Published: 2021

Journal Articles

Large Granular Lymphocytosis and Its Impact on Long Term Clinical Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation: 14-Year Follow-up Data

Guldane Cengiz Seval, Atilla Uslu, MD, Ekin Kircali, Sinem Civriz Bozdag, MD, Klara Dalva, MD, Selami Kocak Toprak, MD, Meltem Kurt Yuksel, MD, Pervin Topcuoglu, MD, Isinsu Kuzu, Onder Arslan, Muhit Özcan, Taner Demirer, MD, Osman Ilhan, MD, Hamdi Akan, MD, Meral Beksac, MD, Gunhan Gurman, MD

Blood (2019) 134 (Supplement_1): 2019.

https://doi.org/10.1182/blood-2019-128750

Published: 2019

Journal Articles

Effect of Cyclophosphamide on Hemorrhagic Cystitis Following Haploidentical Related Compared to Matched Related/Unrelated Donor Hematopoietic Stem Cell Transplantation: A 7-Year Tertiary Center Analysis

Guldane Cengiz Seval, Nergis Ozturk, Sinem Civriz Bozdag, MD, Meltem Kurt Yuksel, MD, Pervin Topcuoglu, MD, Onder Arslan, Muhit Özcan, Taner Demirer, MD, Gunhan Gurman, MD, Osman Ilhan, Hamdi Akan, MD, Meral Beksac, MD, Selami Kocak Toprak, MD

Blood (2019) 134 (Supplement_1): 4504.

https://doi.org/10.1182/blood-2019-127651

Published: 2019

Journal Articles

Which One, Generic Vs Original Glivec Is More Effective in Patients with Chronic Myeloid Leukemia?

Ekin Kircali, Guldane Cengiz Seval, Sinem Civriz Bozdag, MD, Selami Kocak Toprak, MD, Meltem Kurt Yuksel, MD, Onder Arslan, Muhit Özcan, Taner Demirer, MD, Gunhan Gurman, MD, Osman Ilhan, Hamdi Akan, MD, Meral Beksac, MD, Pervin Topcuoglu, MD

Blood (2019) 134 (Supplement_1): 4156.

https://doi.org/10.1182/blood-2019-127622

Published: 2019

Journal Articles

Impact of ABO Mismatch on Outcomes of Allogeneic Hematopoietic Stem Cell Recipients: 30 Years of Experience with 1016 Patients

Erden Atilla, MD, Pervin Topcuoglu, MD, Erman Akkus, MD, Pinar Ataca Atilla, MD, Sinem Civriz Bozdag, MD, Meltem Kurt Yuksel, MD, Taner Demirer, MD, Muhit Özcan, Meral Beksac, MD, Osman Ilhan, MD, Hamdi Akan, MD, Onder Arslan, MD, Gunhan Gurman, MD, Selami Kocak Toprak, MD

Blood (2018) 132 (Supplement 1): 3472.

https://doi.org/10.1182/blood-2018-99-118314

Published: 2018

Journal Articles

Retrospective Analysis of 149 Unselected Patients with Mantle Cell Lymphoma Confirms Prognostic Relevance of Mantle Cell Lymphoma International Prognostic Index: Single Center Experience

Guldane Cengiz Seval, Bahar Ulas, Onur Tascı, Fulya Ozel, MD, Buğu Bulat, Isinsu Kuzu, Sinem Civriz Bozdag, MD, Selami Kocak Toprak, MD, Meltem Kurt Yuksel, MD, Pervin Topcuoglu, MD, Muhit Özcan, Meral Beksac, MD, Osman Ilhan, MD, Gunhan Gurman, Onder Arslan

Blood (2018) 132 (Supplement 1): 5331.

https://doi.org/10.1182/blood-2018-99-120370

Published: 2018

Journal Articles

Donor Lymphocyte Infusions for Relapsed Hematological Malignancies after Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience

Gunhan Gurman, MD, Guldane Cengiz Seval, Sinem Civriz Bozdag, MD, Selami Kocak Toprak, MD, Meltem Kurt Yuksel, MD, Pervin Topcuoglu, MD, Onder Arslan, MD, Muhit Özcan, Taner Demirer, MD, Osman Ilhan, MD, Meral Beksac, MD, Hamdi Akan, MD

Blood (2018) 132 (Supplement 1): 4673.

https://doi.org/10.1182/blood-2018-99-120202

Published: 2018

Journal Articles

Comparision of Outcomes According to HLA Disparity in Acute Leukemia Patients: A Single Center Institution Experience

Pervin Topcuoglu, MD, Guldane Cengiz Seval, Sinem Civriz Bozdag, MD, Selami Kocak Toprak, MD, Meltem Kurt Yuksel, MD, Klara Dalva, MD, Onder Arslan, MD, Muhit Özcan, Taner Demirer, MD, Osman Ilhan, MD, Meral Beksac, MD, Gunhan Gurman, MD

Blood (2018) 132 (Supplement 1): 5776.

https://doi.org/10.1182/blood-2018-99-120166

Published: 2018

Journal Articles

Age Is Not Important for Autologous Peripheral Hematopoietic Stem Cell Transplantation in Multiple Myeloma

Osman Ilhan, MD, Guldane Cengiz Seval, Selami Kocak Toprak, MD, Pervin Topcuoglu, MD, Fulya Ozel, MD, Sinem Civriz Bozdag, MD, Meltem Yuksel, MD, Onder Arslan, MD, Muhit Ozcan, MD, Taner Demirer, MD, Hamdi Akan, Meral Beksac, MD, Gunhan Gurman

Blood (2017) 130 (Supplement 1): 5480.

https://doi.org/10.1182/blood.V130.Suppl_1.5480.5480

Published: 2017

Journal Articles

Dilemma-High Response Rates Vs High Toxicity: Autologous Stem Cell Transplantation for Lymphoma

Erden Atilla, MD, Selami Kocak Toprak, MD, Sinem Civriz Bozdag, MD, Meltem Yuksel, MD, Pervin Topcuoglu, MD, Hamdi Akan, MD, Onder Arslan, MD, Taner Demirer, MD, Meral Beksac, MD, Osman Ilhan, MD, Muhit Ozcan, MD, Gunhan Gurman, MD

Blood (2017) 130 (Supplement 1): 5528.

https://doi.org/10.1182/blood.V130.Suppl_1.5528.5528

Published: 2017

Journal Articles

Long-Term Results of Brentuximab Vedotin in Relapsed and Refractory Hodgkin Lymphoma: Multi-Center Real-Life Experience

A. Burhan Ferhanoglu, MD, Murat Özbalak, Ayse Salihoglu, MD, Teoman Soysal, MD, ihsan Karadoğan, Semra Paydas, MD, Evren Ozdemir, MD, Birol Yıldız, Nuri Karadurmuş, Leylagül Kaynar, Zeynep Arzu Yeğin, Ezgi Pınar Özbalak, Gülsan Sucak, Vildan Ozkocaman, MD, Pervin Topçuoğlu, Muhit Ozcan, MD, Elif Birtas, Hakan Goker, MD

Blood (2017) 130 (Supplement 1): 5173.

https://doi.org/10.1182/blood.V130.Suppl_1.5173.5173

Published: 2017

Journal Articles

Comparison of Reduced Intensity Conditioning (RIC) Regimen and Myeloablative Conditioning (MAC) Regimen in Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) for Adult Patients with Acute Leukemia

Gunhan Gurman, MD, Gozde Aydemir Guloksuz, MD, Erden Atilla, MD, Pinar Ataca Atilla, MD, Sinem Civriz Bozdag, MD, Meltem Kurt Yuksel, MD, Selami Kocak Toprak, MD, Pervin Topcuoglu, MD, Onder Arslan, MD, Muhit Ozcan, MD, Taner Demirer, MD, Osman Ilhan, MD, Hamdi Akan, MD, Meral Beksac, MD

Blood (2016) 128 (22): 5757.

https://doi.org/10.1182/blood.V128.22.5757.5757

Published: 2016

Journal Articles

Does Donor Epstein-Barr Virus (EBV) Seropositivity Affect Recipient's Risk of Graft Versus Host Disease (GVHD) in Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)?

Erden Atilla, MD, Esmanur Kaplan, MD, Pinar Ataca Atilla, MD, Selami Kocak Toprak, MD, Pervin Topcuoglu, MD, Hamdi Akan, MD

Blood (2016) 128 (22): 5766.

https://doi.org/10.1182/blood.V128.22.5766.5766

Published: 2016

Journal Articles

Does Hypogammaglobulinemia at Diagosis Effects Survival and Infection Risk in Chronic Lymphocytic Leukemia (CLL)?

Erden Atilla, MD, Pinar Ataca Atilla, MD, Sinem Civriz Bozdag, MD, Selami Kocak Toprak, MD, Pervin Topcuoglu, MD, Osman Ilhan, MD, Muhit Ozcan, MD, Onder Arslan, MD

Blood (2016) 128 (22): 5577.

https://doi.org/10.1182/blood.V128.22.5577.5577

Published: 2016

Journal Articles

Therapeutic Plasma Exchange for Thrombotic Microangiopathy

Osman Ilhan, MD, Erden Atilla, MD, Pinar Ataca Atilla, MD, Sinem Civriz Bozdag, MD, Meltem Kurt Yuksel, MD, Selami Kocak Toprak, MD, Pervin Topcuoglu, MD, Hamdi Akan, MD, Taner Demirer, MD, Meral Beksac, MD, Onder Arslan, MD, Muhit Ozcan, MD, Gunhan Gurman, MD

Blood (2016) 128 (22): 4939.

https://doi.org/10.1182/blood.V128.22.4939.4939

Published: 2016

NARROW

Allogeneic Stem Cell Transplantation for Relapsed and/or Refractory Hodgkin Lymphoma: A Multicenter Real World Experience

A Single Center Real-World Data Comparing Salvage Autologous Hematopoietic Stem-Cell Transplantation, Selinexor Combo and Elranatamab Alone Among Triple Class Refractory Myeloma Patients: Better Efficacy with Elranatamab

Single Center Real World Data That Compares Autologous Stem Cell Transplant in the Era of Anti-CD38 Monoclonal Antibody Based Treatments for AL Amyloidosis

The Impact of CD34+ Cell and Immunefector Cell Dose on Transplant Outcomes

The Outcome of Autologous Hematopoietic Cell Transplantation in Elderly Patients with Aggressive Non-Hodgkin Lymphoma

Comparison of Salvage Autologous Hematopoietic Cell Transplantation with Outcomes Following Selinexor Combinations Among Double/Triple Refractory Myeloma Patients

Large Granular Lymphocytosis and Its Impact on Long Term Clinical Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation: 14-Year Follow-up Data

Effect of Cyclophosphamide on Hemorrhagic Cystitis Following Haploidentical Related Compared to Matched Related/Unrelated Donor Hematopoietic Stem Cell Transplantation: A 7-Year Tertiary Center Analysis

Which One, Generic Vs Original Glivec Is More Effective in Patients with Chronic Myeloid Leukemia?

Impact of ABO Mismatch on Outcomes of Allogeneic Hematopoietic Stem Cell Recipients: 30 Years of Experience with 1016 Patients

Retrospective Analysis of 149 Unselected Patients with Mantle Cell Lymphoma Confirms Prognostic Relevance of Mantle Cell Lymphoma International Prognostic Index: Single Center Experience

Donor Lymphocyte Infusions for Relapsed Hematological Malignancies after Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience

Comparision of Outcomes According to HLA Disparity in Acute Leukemia Patients: A Single Center Institution Experience

Age Is Not Important for Autologous Peripheral Hematopoietic Stem Cell Transplantation in Multiple Myeloma

Dilemma-High Response Rates Vs High Toxicity: Autologous Stem Cell Transplantation for Lymphoma

Long-Term Results of Brentuximab Vedotin in Relapsed and Refractory Hodgkin Lymphoma: Multi-Center Real-Life Experience

Comparison of Reduced Intensity Conditioning (RIC) Regimen and Myeloablative Conditioning (MAC) Regimen in Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) for Adult Patients with Acute Leukemia

Does Donor Epstein-Barr Virus (EBV) Seropositivity Affect Recipient's Risk of Graft Versus Host Disease (GVHD) in Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)?

Does Hypogammaglobulinemia at Diagosis Effects Survival and Infection Risk in Chronic Lymphocytic Leukemia (CLL)?

Therapeutic Plasma Exchange for Thrombotic Microangiopathy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only